206 related articles for article (PubMed ID: 27825413)
1. Risk Factors of Lymphnode Metastasis in Patients with Thyroid Papillary Carcinoma Associated with Graves Disease.
Xie Y; Liu YW; Wang MY; Wang WZ; Liu HF; Li XY; Gao WS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Oct; 38(5):554-558. PubMed ID: 27825413
[TBL] [Abstract][Full Text] [Related]
2. [Clinical analysis of lymphocytic thyroiditis coexistent with papillary thyroid carcinoma].
Wang SX; She ZQ; An CM; Zhang XW; Li ZJ; Tang PZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 51(4):277-81. PubMed ID: 27095720
[TBL] [Abstract][Full Text] [Related]
3. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
[TBL] [Abstract][Full Text] [Related]
4. [Risk factors of level Ⅵ lymph node metastasis in cN0 papillary thyroid carcinoma].
Ma N; Li JR; Guo HG
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 30(8):641-644. PubMed ID: 29871097
[No Abstract] [Full Text] [Related]
5. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
Wu MH; Shen WT; Gosnell J; Duh QY
Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
[TBL] [Abstract][Full Text] [Related]
6. Sonographic features of primary tumor as independent predictive factors for lymph node metastasis in papillary thyroid carcinoma.
Wu Q; Li Y; Wang Y; Hu B
Clin Transl Oncol; 2015 Oct; 17(10):830-4. PubMed ID: 26041723
[TBL] [Abstract][Full Text] [Related]
7. [Significance of selective neck dissection in patients with cN0 thyroid carcinoma].
Li ZJ; An CM; Yan DG; Zhang XW; Zhang ZM; Xu ZG; Tang PZ
Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):783-6. PubMed ID: 24378103
[TBL] [Abstract][Full Text] [Related]
8. Clinical features of multifocal papillary thyroid carcinoma and risk factors of cervical metastatic lymph nodes.
Ni Y; Wang T; Wang X; Tian Y; Wei W; Liu Q
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 51(2):225-232. PubMed ID: 36161301
[TBL] [Abstract][Full Text] [Related]
9. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma.
Baek SK; Jung KY; Kang SM; Kwon SY; Woo JS; Cho SH; Chung EJ
Thyroid; 2010 Feb; 20(2):147-52. PubMed ID: 19785522
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of the patterns of cervical lymph node recurrence in patients with cN0 papillary thyroid carcinoma after central neck lymph node dissection].
Huang H; Xu Z; Wang X; Wu Y; Liu S
Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):771-5. PubMed ID: 26813598
[TBL] [Abstract][Full Text] [Related]
11. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
[TBL] [Abstract][Full Text] [Related]
12. [Clinical features of postoperative cervical lymph nodes recurrence in papillary thyroid carcinoma].
He YY; Zhang B; Zhang YB; Xu ZG; Tang PZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):416-420. PubMed ID: 28635212
[No Abstract] [Full Text] [Related]
13. [The value of thyroglobulin measurement in fine-needle aspiration for diagnosis of suspicious lymph nodes in patients with thyroid carcinoma after thyroidectomy].
Li Q; Zhao B; Lyu J; Shou J; Xu H; Xu L; Gao L; Zhang M; Zhu J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 May; 51(5):378-82. PubMed ID: 27220299
[TBL] [Abstract][Full Text] [Related]
14. [Study on the relationship between ultrasonographic features of papillary thyroid carcinoma and central cervical lymph node metastasis].
Wang XQ; Wei W; Wei X; Xu Y; Wang HL; Xing XJ; Zhang S
Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):196-200. PubMed ID: 29575838
[No Abstract] [Full Text] [Related]
15. Thyroglobulin level in fine-needle aspirates for preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma: two different cutoff values according to serum thyroglobulin level.
Jeon MJ; Kim WG; Jang EK; Choi YM; Lee YM; Sung TY; Yoon JH; Chung KW; Hong SJ; Baek JH; Lee JH; Kim TY; Shong YK; Kim WB
Thyroid; 2015 Apr; 25(4):410-6. PubMed ID: 25607926
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of lymph node jump metastasis in papillary thyroid carcinoma].
Qiao L; Dong C; Zhang N; Ma BL
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Apr; 32(7):522-526. PubMed ID: 29798083
[No Abstract] [Full Text] [Related]
17. Pre-ablation stimulated thyroglobulin is a better predictor of recurrence in pathological N1a papillary thyroid carcinoma than the lymph node ratio.
Chang YW; Kim HS; Jung SP; Kim HY; Lee JB; Bae JW; Son GS
Int J Clin Oncol; 2016 Oct; 21(5):862-868. PubMed ID: 26837274
[TBL] [Abstract][Full Text] [Related]
18. [Role of level VI lymph nodes metastasis in cervical metastasis of patients with papillary thyroid cancer].
Bian X; Chen H; Ye X; Tang PZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Aug; 45(8):664-8. PubMed ID: 21055244
[TBL] [Abstract][Full Text] [Related]
19. Using Ultrasonography to Evaluate the Relationship between Capsular Invasion or Extracapsular Extension and Lymph Node Metastasis in Papillary Thyroid Carcinomas.
Jiao WP; Zhang L
Chin Med J (Engl); 2017 Jun; 130(11):1309-1313. PubMed ID: 28524830
[TBL] [Abstract][Full Text] [Related]
20. Higher incidence of tall cell variant of papillary thyroid carcinoma in Graves' Disease.
Boutzios G; Vasileiadis I; Zapanti E; Charitoudis G; Karakostas E; Ieromonachou P; Karatzas T
Thyroid; 2014 Feb; 24(2):347-54. PubMed ID: 23786233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
